This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Marshall, A. 1997. Bio/Technology 15:954–957.
Department of Health and Human Services, US Food and Drug Administration. 1997. Guidance for Industry. Drug Metabolism/Drug Interaction Studies in the Drug Development Process: Studies in Vitro. The Drug Information Branch (HFD-210), Rockville, MD.
Meyer, U.A. 1997. Medically relevant genetic variation of drug effects. Evolution in Health and Disease. Oxford University Press, Oxford, UK.
Rights and permissions
About this article
Cite this article
Hodgson, J., Marshall, A. Pharmacogenomics: Will the regulators approve?. Nat Biotechnol 16, 243–246 (1998). https://doi.org/10.1038/nbt0398-243
Issue Date:
DOI: https://doi.org/10.1038/nbt0398-243
This article is cited by
-
The art, science and philosophy of child care
The Indian Journal of Pediatrics (2009)
-
Primer: molecular tools used for the understanding of endocrinology
Nature Clinical Practice Endocrinology & Metabolism (2007)
-
Economic and regulatory considerations in pharmacogenomics for drug licensing and healthcare
Nature Biotechnology (2003)
-
Criteria for genetic screening: the impact of pharmaceutical research
Monash Bioethics Review (1999)
